RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
Fever is now more often a sign of serious bacterial infection
RI-MUHC researchers advocate for extra vigilance with feverish infants as new study shows startling numbers of serious bacterial infections during...
Does the COVID-19 vaccine work for people living with HIV?
RI-MUHC scientist Dr. Cecilia Costiniuk is co-principal investigator in a new national study that hopes to answer critical questions around the...
How does the hunger-suppressing hormone leptin cross the blood-brain barrier?
Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC
Recurrent miscarriage: what if the cause is genetic?
Next-generation gene sequencing may provide answers for some women dealing with recurrent pregnancy loss and prevent further miscarriages
New study paves the way to novel treatment for Triple Negative Breast Cancer
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development...
RI-MUHC study explores how to overcome the resistance of bladder tumours to radiation therapy
Work published in Nature Communications demonstrates a...
Tracking the emerging COVID-19 variants of concern in Canada
RI-MUHC researcher Ciriaco Piccirillo takes a leading role in Canada’s new Coronavirus Variants Rapid Response Network
When will I fully recover from surgery? New study highlights patients’ perspectives on postoperative recovery
The meaning of recovery goes beyond traditional clinical parameters
New research looks at vaccination efficacy and hemodialysis
Dialysis patients do not develop adequate antibodies with one dose of SARS-CoV-2 vaccine